Springe direkt zu Inhalt

Absence of relationship between CDAI or CRP and infliximab exposure calls for use of objective Crohn’s disease activity measures for evaluation of treatment effects at treatment failure

H. Edlund, A.M. Grisic, C. Steenholdt, M.A. Ainsworth, J. Brynskov, W. Huisinga, C. Kloft – 2019

Titel
Absence of relationship between CDAI or CRP and infliximab exposure calls for use of objective Crohn’s disease activity measures for evaluation of treatment effects at treatment failure
Verfasser
H. Edlund, A.M. Grisic, C. Steenholdt, M.A. Ainsworth, J. Brynskov, W. Huisinga, C. Kloft
Verlag
Therapeutic Drug Monitoring
Datum
2019-04-01
Quelle/n
Art
Text